Resumen
This review discusses new radiotracers for diagnosing and treating thyroid cancer. It focuses on PSMA-based tracers, FAPI-based tracers, RGD-based tracers, and 18F-TFB. These tracers show promise in detecting thyroid cancer, especially in challenging cases. They offer better accuracy and help in choosing the right treatment. Further research is needed, especially on the promising 18F-TFB and FAP-targeting tracers, to improve thyroid cancer staging and treatment outcomes.